The Effect of Detemir Compared to Exenatide and/or the Combination of Detemir and Exenatide on Glycemic Control and Weight in Patients With Type 2 Diabetes Mellitus Who Have Failed Oral Hypoglycemic Agents.
Phase of Trial: Phase IV
Latest Information Update: 24 Jun 2011
At a glance
- Drugs Exenatide; Insulin detemir
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 24 Jun 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 24 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.